Q2FY27 · Consolidated

NURECA reports Rs 4.05 cr consolidated profit in Q2FY27

Operating profit was Rs 5.23 cr, while Rs 1.35 cr of other income supported the Rs 5.52 cr pre-tax profit.

By Ashutosh

Filed 21 Oct 2026, 13:55 IST · NURECA (NURECA)

Key takeaways

  • Consolidated operating margin was 8.93%, leaving limited room between revenue and expenses in Q2FY27.
  • Other income of Rs 1.35 cr contributed to profit before tax of Rs 5.52 cr, making earnings quality an important read.
  • A 26.56% tax rate reduced profit before tax of Rs 5.52 cr to net profit of Rs 4.05 cr.

Operating profit leaves a narrow buffer

Revenue of Rs 58.53 cr generated operating profit of Rs 5.23 cr, implying an operating margin of 8.93%. Expenses of Rs 53.30 cr absorbed most of revenue, leaving limited room for cost increases before operating earnings are affected.

Other income supports pre-tax earnings

Other income of Rs 1.35 cr supplemented operating profit in producing profit before tax of Rs 5.52 cr. This means the reported pre-tax result was not generated entirely by the core operating business.

Tax takes a sizeable slice of profit

The 26.56% tax rate reduced profit before tax of Rs 5.52 cr to net profit of Rs 4.05 cr. Basic EPS was Rs 4.25, so the next results will show whether earnings remain primarily driven by operating profit rather than other income.

Q2FY27 at a glance

Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.

Line itemQ2FY27
Revenue₹59 cr
Other income₹1 cr
Expenses₹53 cr
Operating profit₹5 cr
Operating margin (%)8.93%
Interest₹0 cr
Depreciation₹1 cr
Profit before tax₹6 cr
Tax₹1 cr
Net profit₹4 cr
EPS (₹)₹4.25

What to watch

  • Whether operating margin moves above or below 8.93%.
  • Whether other income remains near Rs 1.35 cr or changes its contribution to profit before tax.
  • Whether the tax rate moves from 26.56% and changes the conversion of profit before tax into net profit.

Figures are as filed by the company with the NSE and are reproduced automatically. Educational market commentary only — not investment advice and not a recommendation to buy or sell any security. Results filed 21 Oct '26.